Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

S&P Pharmaceuticals SPDR (XPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fund basics

See More

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.94 +4.91%
on 11/07/17
43.41 -3.48%
on 10/20/17
-0.98 (-2.29%)
since 10/17/17
3-Month
39.94 +4.91%
on 11/07/17
44.15 -5.10%
on 10/04/17
+1.35 (+3.33%)
since 08/17/17
52-Week
37.16 +12.76%
on 01/31/17
44.50 -5.84%
on 07/25/17
+0.57 (+1.38%)
since 11/17/16

Most Recent Stories

More News
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 41.90 (+0.19%)
JNJ : 138.05 (-0.59%)
MRK : 55.25 (+0.15%)
PJP : 62.10 (-0.10%)
IHE : 150.11 (-0.70%)
LLY : 83.12 (-0.38%)
PPH : 55.82 (-0.08%)
PFE : 35.25 (-0.87%)
BMY : 61.27 (-0.97%)
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 41.90 (+0.19%)
JNJ : 138.05 (-0.59%)
MRK : 55.25 (+0.15%)
PJP : 62.10 (-0.10%)
IHE : 150.11 (-0.70%)
LLY : 83.12 (-0.38%)
PPH : 55.82 (-0.08%)
PFE : 35.25 (-0.87%)
BMY : 61.27 (-0.97%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 41.90 (+0.19%)
PJP : 62.10 (-0.10%)
IHE : 150.11 (-0.70%)
PPH : 55.82 (-0.08%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 41.90 (+0.19%)
PJP : 62.10 (-0.10%)
IHE : 150.11 (-0.70%)
PPH : 55.82 (-0.08%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 41.90 (+0.19%)
JNJ : 138.05 (-0.59%)
MRK : 55.25 (+0.15%)
IHE : 150.11 (-0.70%)
PJP : 62.10 (-0.10%)
LLY : 83.12 (-0.38%)
PFE : 35.25 (-0.87%)
BMY : 61.27 (-0.97%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 41.90 (+0.19%)
JNJ : 138.05 (-0.59%)
MRK : 55.25 (+0.15%)
IHE : 150.11 (-0.70%)
PJP : 62.10 (-0.10%)
LLY : 83.12 (-0.38%)
PFE : 35.25 (-0.87%)
BMY : 61.27 (-0.97%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 41.90 (+0.19%)
PJP : 62.10 (-0.10%)
IHE : 150.11 (-0.70%)
PPH : 55.82 (-0.08%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 41.90 (+0.19%)
PJP : 62.10 (-0.10%)
IHE : 150.11 (-0.70%)
PPH : 55.82 (-0.08%)
Republicans Present Healthcare Bill: Top 5 Gainers

Healthcare stocks posted record highs, with hospitals and insurers climbing after Senate Republicans released a draft bill to replace Obamacare.

XPH : 41.90 (+0.19%)
LNTH : 21.95 (+0.46%)
MOH : 74.70 (-1.32%)
HCA : 75.42 (-0.72%)
AEL : 29.55 (-0.30%)
HIIQ : 23.85 (+0.21%)
ANTM : 221.18 (+0.13%)
CNC : 95.36 (-0.60%)
XBI : 81.41 (-0.02%)
THC : 13.23 (-2.72%)
CBM : 48.40 (+0.21%)
Trump Wins Healthcare Vote: ETFs to Watch

The bill is expected to cut billions of dollars in health-care spending and result in millions of Americans going without health insurance.

HUM : 234.91 (-0.42%)
XHS : 57.25 (-0.71%)
CNCR : 24.69 (+1.06%)
IHF : 147.26 (-0.41%)
HCA : 75.42 (-0.72%)
PPH : 55.82 (-0.08%)
IHI : 174.23 (-0.18%)
UNH : 209.98 (-0.54%)
THC : 13.23 (-2.72%)
AET : 174.77 (+0.01%)
XPH : 41.90 (+0.19%)
FBT : 122.35 (+0.23%)
FTXH : 19.95 (-0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Fund Summary

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 42.27
1st Resistance Point 42.04
Last Price 41.90
1st Support Level 41.43
2nd Support Level 41.05

See More

52-Week High 44.50
Last Price 41.90
Fibonacci 61.8% 41.70
Fibonacci 50% 40.83
Fibonacci 38.2% 39.96
52-Week Low 37.16

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart